The Journal of Neuroscience, November 11, 2009, 29(45):14177-14184; doi:10.1523/JNEUROSCI.3238-09.2009
Previous Article | Next Article 
Neurobiology of Disease
NOS2 Gene Deficiency Protects from Sepsis-Induced Long-Term Cognitive Deficits
Marc Weberpals,1
Michael Hermes,1
S. Hermann,2
Markus P. Kummer,1
Dick Terwel,1
Alexander Semmler,1
Meike Berger,3
Michael Schäfers,4 and
Michael T. Heneka1
1Department of Neurology, University of Bonn, 53127 Bonn, Germany, and 2Departments of Nuclear Medicine and 3Physiology I and 4European Institute of Molecular Imaging, University of Münster, 48149 Münster, Germany
Correspondence should be addressed to Dr. Michael T. Heneka, Department of Neurology, Clinical Neuroscience, Sigmund-Freud-Strasse 33, 53127 Bonn, Germany. Email: michael.heneka{at}ukb.uni-bonn.de
To date, long-term consequences of septic encephalopathy on cerebral metabolism, cognition, learning, and memory capabilities and factors involved are poorly understood. In this study, we used a murine sepsis model to demonstrate that bacterial lipopolysaccharide (LPS) causes long-term cognitive deficits in mice. Two months after LPS treatment, wild-type mice committed more working and reference memory errors than controls. The behavioral impairment was independent of the cerebral glucose uptake as evidenced by 18F-Fluordeoxyglucose small animal positron emission tomography. In contrast, mice deficient for the inducible nitric oxide synthase gene (NOS2–/–) did not show any cognitive changes when challenged with LPS. Immunohistochemical analysis demonstrated that LPS did not lead to neuronal cell death but caused sustained microglial activation in wild-type as compared to NOS2–/– mice. Expression analysis showed that LPS-treated NOS2–/– mice had lower brain mRNA levels for proinflammatory factors compared with wild-type mice. Expression analysis demonstrated distinct changes in the content of synaptic proteins in wild-type mice, which were not observed in the NOS2–/– mice. Together, this data set outlines the importance of the NOS2 activation for long-term cerebral changes after severe sepsis.
Received July 8, 2009;
revised Sept. 16, 2009;
accepted Sept. 17, 2009.
Correspondence should be addressed to Dr. Michael T. Heneka, Department of Neurology, Clinical Neuroscience, Sigmund-Freud-Strasse 33, 53127 Bonn, Germany. Email: michael.heneka{at}ukb.uni-bonn.de